Modelling the Effect of Short-Course Multidrug-Resistant Tuberculosis Treatment in Karakalpakstan, Uzbekistan

Hdl Handle:
http://hdl.handle.net/10144/618718
Title:
Modelling the Effect of Short-Course Multidrug-Resistant Tuberculosis Treatment in Karakalpakstan, Uzbekistan
Authors:
Trauer, JM; Achar, J; Parpieva, N; Khamraev, A; Denholm, JT; Falzon, D; Jaramillo, E; Mesic, A; du Cros, P; McBryde, ES
Journal:
BMC Medicine
Abstract:
Multidrug-resistant tuberculosis (MDR-TB) is a major threat to global TB control. MDR-TB treatment regimens typically have a high pill burden, last 20 months or more and often lead to unsatisfactory outcomes. A 9-11 month regimen with seven antibiotics has shown high success rates among selected MDR-TB patients in different settings and is conditionally recommended by the World Health Organization.
Publisher:
BioMed Central
Issue Date:
18-Nov-2016
URI:
http://hdl.handle.net/10144/618718
DOI:
10.1186/s12916-016-0723-2
PubMed ID:
27855693
Submitted date:
2016-11-28
Language:
en
ISSN:
1741-7015
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorTrauer, JMen
dc.contributor.authorAchar, Jen
dc.contributor.authorParpieva, Nen
dc.contributor.authorKhamraev, Aen
dc.contributor.authorDenholm, JTen
dc.contributor.authorFalzon, Den
dc.contributor.authorJaramillo, Een
dc.contributor.authorMesic, Aen
dc.contributor.authordu Cros, Pen
dc.contributor.authorMcBryde, ESen
dc.date.accessioned2016-11-29T15:58:18Z-
dc.date.available2016-11-29T15:58:18Z-
dc.date.issued2016-11-18-
dc.date.submitted2016-11-28-
dc.identifier.citationModelling the Effect of Short-Course Multidrug-Resistant Tuberculosis Treatment in Karakalpakstan, Uzbekistan. 2016, 14 (1):187 BMC Meden
dc.identifier.issn1741-7015-
dc.identifier.pmid27855693-
dc.identifier.doi10.1186/s12916-016-0723-2-
dc.identifier.urihttp://hdl.handle.net/10144/618718-
dc.description.abstractMultidrug-resistant tuberculosis (MDR-TB) is a major threat to global TB control. MDR-TB treatment regimens typically have a high pill burden, last 20 months or more and often lead to unsatisfactory outcomes. A 9-11 month regimen with seven antibiotics has shown high success rates among selected MDR-TB patients in different settings and is conditionally recommended by the World Health Organization.en
dc.languageENG-
dc.language.isoenen
dc.publisherBioMed Centralen
dc.rightsArchived with thanks to BMC Medicineen
dc.titleModelling the Effect of Short-Course Multidrug-Resistant Tuberculosis Treatment in Karakalpakstan, Uzbekistanen
dc.identifier.journalBMC Medicineen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.